Senthil Sundaram, Terns CEO
Eli Lilly's transpacific bosom buddy Terns bags late-round funding to drive NASH hopefuls through the clinic
In a hot market market for NASH, having big-name backers can help shine a spotlight on startup players looking to make a mark. That was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
